Primary prevention of hepatitis C virus infection

被引:6
|
作者
Zanetti, AR [1 ]
Romanò, L [1 ]
Bianchi, S [1 ]
机构
[1] Univ Milan, Ist Virol, Fac Med, I-20133 Milan, Italy
关键词
hepatitis C; HCV transmission; primary prevention;
D O I
10.1016/S0264-410X(02)00581-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Viral hepatitis type C is a worldwide public health problem of major concern. Waiting for a safe and effective vaccine able to confer protection to susceptible individuals, public health challenges for controlling hepatitis C require implementation of primary prevention measures that reduce risks of acquiring/transmitting HCV infection. Screening for safe blood and blood products, use of disposable syringes and needles and of universal precautions have dramatically reduced risk of infection in medical setting. Health education, counselling and testing of individuals at risk provide opportunities for controlling HCV infection. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:692 / 695
页数:4
相关论文
共 50 条
  • [31] Hepatitis C virus infection
    Manns, Michael P.
    Buti, Maria
    Gane, Ed
    Pawlotsky, Jean-Michel
    Razavi, Homie
    Terrault, Norah
    Younossi, Zobair
    NATURE REVIEWS DISEASE PRIMERS, 2017, 3
  • [32] Hepatitis C virus infection
    Kazatchkine, M
    M S-MEDECINE SCIENCES, 2002, 18 (03): : 263 - 264
  • [34] Hepatitis C virus infection
    Fralick, Michael
    Feld, Jordan J.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2015, 187 (15) : 1159 - 1159
  • [35] Primary splenic malignant lymphoma associated with hepatitis C virus infection
    K. Kishimoto
    T. Koyama
    Y. Kigami
    H. Kobayashi
    K. Akuta
    K. Ito
    N. Matsunaga
    Abdominal Imaging, 2001, 26 : 55 - 58
  • [36] 1 infection of primary hepatocytes of Tupaia belangeri by hepatitis C virus
    Guitart, A
    Berthillon, P
    Riezu-Boj, JI
    Elizalde, E
    Berby, F
    Maisonnas, M
    Civeira, MP
    Trépo, C
    Prieto, J
    JOURNAL OF HEPATOLOGY, 2001, 34 : 115 - 115
  • [37] Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection
    Lloyd, Andrew R.
    Jagger, Emma
    Post, Jeffrey J.
    Crooks, Lee-Ann
    Rawlinson, William D.
    Hahn, Young S.
    Ffrench, Rosemary A.
    IMMUNOLOGY AND CELL BIOLOGY, 2007, 85 (01): : 24 - 32
  • [38] Evolution of hypervariable region 1 of hepatitis C virus in primary infection
    Manzin, A
    Solforosi, L
    Petrelli, E
    Macarri, G
    Tosone, G
    Piazza, M
    Clementi, M
    JOURNAL OF VIROLOGY, 1998, 72 (07) : 6271 - 6276
  • [39] Primary liver sarcoma in an immunocompetent patient with hepatitis C virus infection
    Alkhatib, Amer A.
    Broaddus, Russell R.
    Jiang, Liuyan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 207 - 208
  • [40] Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
    Arora, Sanjeev
    Thornton, Karla
    Murata, Glen
    Deming, Paulina
    Kalishman, Summers
    Dion, Denise
    Parish, Brooke
    Burke, Thomas
    Pak, Wesley
    Dunkelberg, Jeffrey
    Kistin, Martin
    Brown, John
    Jenkusky, Steven
    Komaromy, Miriam
    Qualls, Clifford
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23): : 2199 - 2207